[1]
Booij J, Tissingh G, Boer GJ, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labeling in early and advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997; 62: 133-40.
[2]
Prashanth R, Roy SD, Mandal PK, Ghosh S. Automatic classification and prediction models for early Parkinson’s disease diagnosis from SPECT imaging. Expert Syst Appl 2014; 41: 3333-42.
[3]
Kaufman MJ, Madras BK. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson’s-diseased striatum. Synapse 1991; 9: 43-9.
[4]
Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 2011; 134: 3146-66.
[5]
Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci 2005; 28: 57-87.
[6]
Booth TC, Nathan M, Waldman AD, Mquigley A, Schapuria AH, Buscombe J. The role of functional dopamine transporter. AJNR Am J Neuroradial 2015; 36: 229-35.
[7]
Fahn S. Description of Parkinson’s disease as a clinical syndrome. Ann N Y Acad Sci 2003; 991: 1-14.
[8]
Bairactaris C, Demakopoulos N, Tripsianis G, et al. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with Parkinsonian syndromes. J Clin Neurosci 2009; 16: 246-52.
[9]
Seifert KD, Wiener JI. The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study. Am J Neurodegener Dis 2013; 2: 29-34.
[11]
Benamer TS, Patterson J, Grosset DG, et al. Accurate differentiation of Parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FPCIT study group. Mov Disord 2000; 15: 503-10.
[12]
Prashanth R, Dutta RS, Ghosh S, Pravat MK. Shape features as biomarkers in early Parkinson’s disease. In: 6th International IEEE/EMBS conference on neural engineering (NER). 2013 Nov 6-8; San Diego, CA, USA. 517-20.
[13]
Prashanth R, Roy SD, Mandal PK, Ghosh S. High accuracy classification of Parkinson’s Disease through shape analysis and surface fitting in 123I-Ioflupane SPECT imaging. IEEE J Biomed Health 2016; 99: 1-9.
[14]
Oliveira FP, Castelo-Branco M. Computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector. J Neural Eng 2015; 12026008
[15]
Martinez–Murcia FJ, Gorrz JM, Ramirez J, Illan IA, Ortiz A. Automatic detection of Parkinsonism using significance measures and component analysis in DaTSCAN imaging. Neurocomputing 2014; 126: 58-70.
[16]
Djang DS, Janssen MJ, Bohnen N, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med 2012; 53: 154-63.
[17]
Ghatehchopogh FS, Mohammadi P. A case study of Parkinson Disease diagnosis using artificial neural network. IJCA 2013; 73: 1-6.
[18]
Orru G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review. Neurosci Biobehav Rev 2012; 36: 1140-52.
[19]
Winogrodzka A, Bergmans P, Booij J, Van Royen EA, Janssen AG, Wolters EC. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson’s disease. J Neural Transm 2001; 108: 1011-9.
[20]
Illan IA, Gorrz JM, Ramirez J, Segovia F, Jimenez-Hoyuela JM, Ortega Lozano SJ. Automatic assistance to Parkinson’s disease diagnosis in DaTSCAN SPECT imaging. Med Phys 2012; 39: 5971-80.
[21]
David GA, Magnus JB. Diagnosing Parkinson by using artificial neural networks and support vector machines. Global J Comput Sci Technol 2009; 9(4): 63-71.
[22]
Avci D, Dogantekin A. An expert system for Parkinson disease based on genetic algorithm-wavelet kernel-extreme learning machine. Parkinsons Dis 2016; 20165264743
[23]
Vijayarani S, Sudha S. An efficient clustering algorithm for predicting diseases from hemogram blood test samples. Indian J Sci Technol 2015; 89(17): 1-8.
[24]
Marek K, Jennings D, Lasch S, et al. The Parkinson progression marker initiative (PPMI). Prog Neurobiol 2011; 95: 629-35.
[25]
Tomasi C, Manduchi R. Bilateral filtering for gray and color images. In: Proceedings of the IEEE International Conference on Computer Vision. 1998 Jan 4-7; Bombay, India. 839-46.
[26]
Masood S, Sharif M, Masood A, Yasmin M, Raza M. A survey on medical image segmentation. Curr Med Imaging 2015; 11: 3-14.
[27]
Georgiadis P, Cavouras D, Kalatzis I, et al. Computeraided discrimination between primary and secondary brain tumors on MRI: From 2D to 3D texture analysis. J Sci Technol 2008; 8: 9-18.
[28]
Sharma N, Ray AK, Sharma S, Shukla KK, Pradhan S, Aggarwal LM. Segmentation and classification of medical images using texture-primitive features: Application of BAM-type artificial neural network. J Med Phys 2008; 33: 119-26.
[29]
Chen H-L, Wang G, Ma C, Cai Z-N, Liu W-B, Wang S-J. An efficient hybrid kernel extreme learning machine approach for early diagnosis of Parkinson’s disease. Neurocomputing 2016; 184: 131-44.
[30]
Boser BE, Guyon IM, Vapnik VN. A training algorithm for optimal
margin classifiers. In: Haussler D, Ed. Proceedings of the 5th Annual
Workshop on Computational Learning Theory (COLT’92).
ACM Press; 1992; Pittsburgh, Pennsylvania, USA; pp. 144-52.